Brief: Innate Pharma End-2022 Cash Position Of EUR 136.6 Million

Innate Pharma SA

23/03/2023 06:09

March 23 (Reuters) - Innate Pharma SA  IPH.PA :
    * CASH POSITION OF EUR 136.6 MILLION AS OF DECEMBER 31, 2022
    * REVENUE AND OTHER INCOME FROM CONTINUING OPERATIONS
AMOUNTED TO
EUR 57.7M IN 2022 (2021: EUR 24.7M)
    * A NET LOSS OF EUR 58.1M IN 2022 (2021: NET LOSS OF EUR
52.8M)
    * TOTAL OPERATING EXPENSES EUR 57.7 MILLION IN 2022

Source text for Eikon:  ID:nBw9BTjDQa 
Further company coverage:  IPH.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))